Literature DB >> 19181605

Deletions of chromosome 1p and 15q are associated with aggressiveness of gastrointestinal stromal tumors.

Yi Chen1, Chiou-Ping Liou, Hui-Hwa Tseng, Yee-Jee Jan, Chien-Fen Li, Ching-Cherng Tzeng.   

Abstract

BACKGROUND/
PURPOSE: Site-dependent profiles of chromosome imbalances (CIs) have been reported in gastrointestinal stromal tumors (GISTs). However, the role of specific CIs in association with metastasis is not clear.
METHODS: Thirteen resected liver metastatic GISTs, including seven from the stomach and six from the small intestine, were analyzed using comparative genomic hybridization (CGH). The CIs associated with metastatic risk were assessed by comparing them with those identified in our previous study of 25 primary GISTs, including 14 from the stomach and 11 from the small intestine.
RESULTS: Synchronous detection of liver metastasis was found more often in patients with intestinal than gastric GIST (5/6 vs. 2/7, p = 0.048). When compared with the primary tumors, the CI profile of liver metastases was similar in the intestinal group, but became more complex in the gastric group. Deletions of chromosomes 1p and 15q were very common (> 80%) in primary and metastatic tumors of the intestinal group, and exhibited a trend towards increase in the metastatic tumors of the gastric group. Both groups had a doubling in the frequency of 22q deletion in the liver metastases, which was not significantly different. Other CIs, including 9p deletion, increased significantly in the liver metastases of the gastric group, but not in the intestinal group.
CONCLUSION: Our results, together with clinical findings, indicated a CGH profile associated with the intrinsic aggressiveness of the GISTs. Deletion of 1p and 15q play a critical role in the acquisition of aggressiveness during early GIST development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19181605     DOI: 10.1016/S0929-6646(09)60029-2

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  5 in total

1.  Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.

Authors:  Nicole M A White; Daniel W Newsted; Olena Masui; Alexander D Romaschin; K W Michael Siu; George M Yousef
Journal:  Tumour Biol       Date:  2013-10-19

2.  Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors.

Authors:  Nelson Lourenço; Zofia Hélias-Rodzewicz; Jean-Baptiste Bachet; Sabrina Brahimi-Adouane; Fabrice Jardin; Jeanne Tran van Nhieu; Frédérique Peschaud; Emmanuel Martin; Alain Beauchet; Frédéric Chibon; Jean-François Emile
Journal:  Mol Cancer       Date:  2014-11-06       Impact factor: 27.401

3.  Small EUS-suspected gastrointestinal stromal tumors of the stomach: An overview for the current state of management.

Authors:  Ender Gunes Yegin; Deniz Guney Duman
Journal:  Endosc Ultrasound       Date:  2016 Mar-Apr       Impact factor: 5.628

4.  Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity.

Authors:  Ludmila Gorunova; Kjetil Boye; Ioannis Panagopoulos; Jeanne-Marie Berner; Bodil Bjerkehagen; Ivar Hompland; Ingvild Lobmaier; Toto Hølmebakk; Tarjei S Hveem; Sverre Heim; Francesca Micci
Journal:  Oncotarget       Date:  2022-03-07

5.  Expression and clinicopathological significance of CD9 in gastrointestinal stromal tumor.

Authors:  Hongxin Yang; Chaoyong Shen; Bo Zhang; Haining Chen; Zhixin Chen; Jiaping Chen
Journal:  J Korean Med Sci       Date:  2013-09-25       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.